U.S. Physical Therapy Past Earnings Performance
Past criteria checks 0/6
U.S. Physical Therapy's earnings have been declining at an average annual rate of -9.9%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been growing at an average rate of 8% per year. U.S. Physical Therapy's return on equity is 4.7%, and it has net margins of 2.2%.
Key information
-9.9%
Earnings growth rate
-11.8%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 8.0% |
| Return on equity | 4.7% |
| Net Margin | 2.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
Nov 09
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
Aug 07U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
Jul 17U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
Jun 04There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
May 21U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
May 11Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
May 05A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Apr 21Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
Apr 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
Mar 04The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
Dec 23Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
Dec 07U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations
Oct 13Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?
Oct 13U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital
Sep 05Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
Aug 15Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?
Aug 01U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)
Jul 19At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?
May 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price
Apr 16U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet
Apr 01Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital
Mar 04U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook
Feb 23U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit
Feb 12Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?
Jan 24We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt
Dec 20Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching
Dec 05U.S. Physical Therapy: Not The Most Comfortable Prospect
Nov 09Revenue & Expenses Breakdown
How U.S. Physical Therapy makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 639 | 14 | 57 | 0 |
| 30 Jun 24 | 621 | 16 | 54 | 0 |
| 31 Mar 24 | 606 | 18 | 52 | 0 |
| 31 Dec 23 | 599 | 18 | 52 | 0 |
| 30 Sep 23 | 585 | 24 | 50 | 0 |
| 30 Jun 23 | 575 | 26 | 50 | 0 |
| 31 Mar 23 | 564 | 28 | 48 | 0 |
| 31 Dec 22 | 548 | 29 | 46 | 0 |
| 30 Sep 22 | 536 | 39 | 45 | 0 |
| 30 Jun 22 | 522 | 38 | 46 | 0 |
| 31 Mar 22 | 509 | 37 | 47 | 0 |
| 31 Dec 21 | 490 | 31 | 47 | 0 |
| 30 Sep 21 | 477 | 31 | 47 | 0 |
| 30 Jun 21 | 461 | 30 | 44 | 0 |
| 31 Mar 21 | 418 | 32 | 41 | 0 |
| 31 Dec 20 | 418 | 32 | 42 | 0 |
| 30 Sep 20 | 423 | 30 | 43 | 0 |
| 30 Jun 20 | 431 | 31 | 43 | 0 |
| 31 Mar 20 | 473 | 29 | 45 | 0 |
| 31 Dec 19 | 477 | 31 | 45 | 0 |
| 30 Sep 19 | 472 | 30 | 44 | 0 |
| 30 Jun 19 | 468 | 23 | 44 | 0 |
| 31 Mar 19 | 457 | 18 | 42 | 0 |
| 31 Dec 18 | 449 | 17 | 41 | 0 |
| 30 Sep 18 | 442 | 18 | 41 | 0 |
| 30 Jun 18 | 432 | 22 | 39 | 0 |
| 31 Mar 18 | 421 | 21 | 38 | 0 |
| 31 Dec 17 | 410 | 22 | 36 | 0 |
| 30 Sep 17 | 392 | 20 | 34 | 0 |
| 30 Jun 17 | 377 | 20 | 33 | 0 |
| 31 Mar 17 | 363 | 21 | 32 | 0 |
| 31 Dec 16 | 353 | 21 | 32 | 0 |
| 30 Sep 16 | 348 | 20 | 34 | 0 |
| 30 Jun 16 | 344 | 21 | 33 | 0 |
| 31 Mar 16 | 337 | 21 | 32 | 0 |
| 31 Dec 15 | 327 | 21 | 31 | 0 |
| 30 Sep 15 | 320 | 21 | 30 | 0 |
| 30 Jun 15 | 313 | 20 | 31 | 0 |
| 31 Mar 15 | 308 | 20 | 31 | 0 |
| 31 Dec 14 | 301 | 19 | 30 | 0 |
| 30 Sep 14 | 290 | 19 | 29 | 0 |
| 30 Jun 14 | 278 | 18 | 28 | 0 |
| 31 Mar 14 | 267 | 18 | 27 | 0 |
| 31 Dec 13 | 260 | 18 | 26 | 0 |
Quality Earnings: USPH has a large one-off loss of $28.5M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: USPH's current net profit margins (2.2%) are lower than last year (4.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: USPH's earnings have declined by 9.9% per year over the past 5 years.
Accelerating Growth: USPH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: USPH had negative earnings growth (-40.6%) over the past year, making it difficult to compare to the Healthcare industry average (10.3%).
Return on Equity
High ROE: USPH's Return on Equity (4.7%) is considered low.